• DSHS HIV/STD Program

    Post Office Box 149347, MC 1873
    Austin, Texas 78714

    Phone: (512) 533-3000

    E-mail the HIV/STD Program

    E-mail data requests to HIV/STD Program - This email can be used to request data and statistics on HIV, TB, and STDs in Texas. It cannot be used to get treatment or infection history for individuals, or to request information on programs and services. Please do not include any personal, identifying health information in your email such as HIV status, Date of Birth, Social Security Number, etc.

    For treatment/testing history, please contact your local Health Department.

    For information on HIV testing and services available to Persons Living with HIV and AIDS, please contact your local HIV services organization.

HIV-STD Program

Program Navigation
HIV/STD Basics header

HIV/STD Basics

  Healthcare Providers header

Healthcare Providers

Get tested for HIV or STDs

Testing positive for HIV: what's next?

Find medical and support services

Get help with medications

Learn about PrEP

HIV/STD educational materials

Learn more about HIV and other STDs


How to report HIV and STDs

HIV/STD testing and treatment guidelines

Help patients connect with services

Help patients get medications

Learn about PrEP

Expedited Partner Therapy

DSHS Laboratory

DSHS HIV/STD Contractors header

DSHS HIV/STD Contractors

  Reports, Data and Policy header

Reports, Data, and Policy

HIV prevention

HIV medical and support services

Routine HIV testing

STD prevention and treatment

HIV/STD/TB surveillance

Funding information



HIV/STD Program reports

Interactive data: new HIV diagnoses | people living with HIV | chlamydia and gonorrhea

Data requests

Texas HIV/STD laws, rules and authorization

Program policies and procedures


Quick Links

HIV Dashboard
Texas HIV/STD Insider
HIV and the Workplace
HIV/STD Educational Materials
Texas HIV Syndicate
Medical Monitoring Project (MMP)
Texas Black Women's Initiative
Test Texas HIV Coalition
Syphilis Elimination

Recent News header

Texas iconCongenital Syphilis Cases on the Rise

Congenital syphilis cases reported to the Texas Department of State Health Services more than doubled last year amid an ongoing increase in syphilis among women of childbearing age and an enhanced public health effort to detect and track cases. There were 367 cases of congenital syphilis in Texas in 2018, up from 164 in 2017.  Learn more

documentProposed Policy Revision – ARIES Security Policy

The DSHS HIV/STD Program is revising the ARIES Security Policy (231.001). The purpose of the policy to define security standards for protecting the confidential information collected and maintained in the AIDS Regional Evaluation System (ARIES) database by the HIV Care Services Data Group within the HIV/STD program. Draft ARIES Security Policy (PDF : 808 kB) | Current Policy. As part of this process, DSHS asks providers, consumers, and interested stakeholders to review these documents and provide comments. We value your opinion and hope that you will take the time to review and give feedback. Please submit comments to Betsy.Cohn@dshs.texas.gov. Public comment will be accepted until January 30, 2020.

documentCDC Releases Update on Status of HIV Testing, Viral Suppression, and PrEP

CDC released Vital Signs: Status of Human Immunodeficiency Virus Testing, Viral Suppression, and HIV Preexposure Prophylaxis — United States, 2013–2018 [CDC] on December 3, 2019.

Texas icon2018 Texas STD Surveillance Report and Texas HIV Annual Report

DSHS released the 2018 Texas STD Surveillance Report (PDF : 2,833 kB) and the 2018 Texas HIV Annual Report (PDF : 433 kB).

Texas iconRevised 10 Questions About HIV, Syphilis, and Pregnancy Brochure

DSHS revised the brochure 10 Questions About HIV, Syphilis, and Pregnancy (PDF : 2,124 kB) to conform with Section 5 of  SB 748 [Texas Legislature] which takes effect on September 1, 2019. DSHS also revised the Spanish version 10 preguntas sobre el VIH, la sífilis y el embarazo (PDF : 2,126 kB).

alertTreatment as Prevention

The CDC recently released a letter encouraging providers to continue spreading the word about the power of viral suppression to improve the health of people with HIV and to prevent the sexual transmission of HIV. For Antiretroviral Therapy (ART), the science is strong and clear; the data show that the effectiveness for ART with viral suppression is estimated to be 100% for preventing sexual transmission of HIV.  Read the letter (PDF : 210 kB).

documentDSHS Updates Pre-Exposure Prophylaxis (PrEP) Position Statement and Releases Dear Colleague Letter for PrEP

DSHS updated the Pre-Exposure Prophylaxis (PrEP) position statement on January 14, 2019. DSHS also released a Dear Colleague letter detailing the current evidence behind PrEP (PDF : 387 kB).

documentRecommendations Regarding the Use of Dolutegravir in Adults and Adolescents with HIV who are Pregnant or of Child-Bearing Potential

An NIH-funded observational surveillance study of birth outcomes among pregnant women on antiretroviral therapy in Botswana identified neural tube defects in four infants born to 426 women who initiated a dolutegravir (DTG)-based regimen prior to pregnancy, and who were still receiving it at the time of conception. The U.S. Department of Health and Human Services Antiretroviral Guidelines Panels are issuing recommendations... Learn more [AIDSinfo.gov]

Alert iconHealth Advisory: Rapidly Growing Clusters of Ongoing HIV Transmission in Texas

DSHS encourages Texas healthcare providers to enhance efforts to prevent, diagnose and treat HIV in the wake of 16 rapidly growing clusters of HIV infections in the state. Laboratory analysis of these infections indicates sustained transmission of genetically similar types of HIV... read the Health Advisory: Rapidly Growing Clusters of Ongoing HIV Transmission in Texas (PDF : 327 kB) and read the Molecular HIV Surveillance - Genotype Clusters Talking Points (PDF : 189 kB)

Mosquito iconCDC Issues Guidance for Preventing Sexual Transmission of Zika Virus

CDC has issued new interim guidance on preventing sexual transmission of Zika virus... Learn more

Syringe iconDrug Resistant Gonorrhea on the Rise

Gonorrhea is developing a resistance to the last classes of drugs available in the U.S. that are able to cure infection... Learn more

This site contains HIV or STD messages that may not be deemed appropriate for all audiences. Since HIV and other STDs are spread primarily through sexual practices or by sharing needles, messages and programs may address these topics. If you are not seeking such information or may be offended by such materials, please exit this web site. Photos on this website are all posed by a model.

Last updated January 24, 2020